Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biotech Stocks To Watch In 2012
Seeking Alpha
Monday, February 6, 2012 - 11:20am
tags:
Astellas, Array Biopharma, AstraZeneca, Celldex, Exelixis, Pfizer, Progenics Pharmaceuticals, Seattle Genetics, Synta
Lilly Freezes Salaries For Most Employees
Pharmalot
Monday, February 6, 2012 - 9:48am
tags:
Eli Lilly, salaries
Neuralstem raises $5.2M in a registered direct offering
The Fly on the Wall
Monday, February 6, 2012 - 9:48am
tags:
Neuralstem, financing, stock offering
FDA questions benefit of Amgen's bone drug for new use in prostate cancer patients
Yahoo/AP
Monday, February 6, 2012 - 9:47am
tags:
FDA, Amgen, prostate cancer, Xgeva
There’s no Stopping Gilead Sciences
Motley Fool
Monday, February 6, 2012 - 9:45am
tags:
Gilead
India's Piramal Healthcare to borrow for future buys
Reuters
Monday, February 6, 2012 - 9:44am
tags:
Piramal Healthcare, M&A, India
Merck to file application this year for insomnia drug
Reuters
Monday, February 6, 2012 - 9:43am
tags:
insomnia, Merck, suvorexant
Small Pharma With Big Compounds: Final Dance With The FDA
Seeking Alpha
Monday, February 6, 2012 - 9:42am
tags:
GSK, AstraZeneca, FDA, Eli Lilly, Pfizer, Vivus, Merck, MAP Pharmaceuticals
Compugen Jumps to 6-Year High in Tel Aviv on Cancer Treatment Technology
Bloomberg
Sunday, February 5, 2012 - 12:32pm
tags:
CompuGen
They Just Don't Get Merck!
The Street
Sunday, February 5, 2012 - 12:28pm
tags:
Merck
AstraZeneca's Shrinking Act Could Increase Its Appeal
Seeking Alpha
Sunday, February 5, 2012 - 12:18pm
tags:
AstraZeneca
2 Life Sciences IPOs Debut Below Target
Seeking Alpha
Sunday, February 5, 2012 - 12:15pm
tags:
Greenway Medical Technologies, Cempra
Lupin Limited: Buy
Hindu Business Line, India
Saturday, February 4, 2012 - 5:06pm
tags:
Lupin
New rules could save billions in prescription drug costs
Boston Herald, MA
Saturday, February 4, 2012 - 5:05pm
tags:
Medicaid
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
BioMedReports
Saturday, February 4, 2012 - 5:01pm
tags:
Threshold Pharmaceuticals, Merck KGaA, TH-302, sarcoma, pancreatic cancer
7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows
Seeking Alpha
Saturday, February 4, 2012 - 4:54pm
tags:
PDL Biopharma, Wellpoint, Aetna, USANA Health Sciences, Cumberland, Depomed, Acadia
Pharmaceutical and Medical Device Companies Shift Medical Education Focus into Emerging Markets
Sacramento Bee, CA
Saturday, February 4, 2012 - 4:51pm
tags:
Is Novo Nordisk Really the Most Sustainable Company in the World?
Triple Pundit
Saturday, February 4, 2012 - 4:47pm
tags:
Novo Nordisk
Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall
Yahoo/BusinessWire
Saturday, February 4, 2012 - 4:40pm
tags:
Pfizer, lawsuits, recalls
Eli Lilly Freezes Salaries as Sales Slip After Best-Seller Faces Generics
Bloomberg
Saturday, February 4, 2012 - 4:38pm
tags:
Eli Lilly, Zyprexa, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.